Cardio Diagnostics Holdings, Inc. received a notice from Nasdaq on June 3, 2024, indicating non-compliance with the minimum bid price rule, as its stock price remained below $1.00 for 30 consecutive days. The company has until December 2, 2024, to meet the requirement, with the possibility of a 180-day extension. During this period, if the stock closes at $1.00 or higher for at least ten consecutive business days, compliance will be regained. The company is considering options, including a reverse stock split, to address the issue. However, there is no guarantee of regaining compliance or avoiding delisting. The company will continue to monitor its stock price and explore all available options to resolve the deficiency.

Cardio Diagnostics Holdings, Inc. received a notice from Nasdaq on June 3, 2024, indicating non-compliance with the minimum bid price rule, as its stock price remained below $1.00 for 30 consecutive days. The company has until December 2, 2024, to meet the requirement, with the possibility of a 180-day extension. During this period, if the stock closes at $1.00 or higher for at least ten consecutive business days, compliance will be regained. The company is considering options, including a reverse stock split, to address the issue. However, there is no guarantee of regaining compliance or avoiding delisting. The company will continue to monitor its stock price and explore all available options to resolve the deficiency.